You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


NICE recommends MSD’s Keytruda in combination with chemotherapy for routine treatment of lung cancer

With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.